Opioid Crisis Knowledge Synthesis

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with Unit

Memorial Deadline: Thursday 30th, November 2017

External Deadline: Tuesday 5th, December 2017


Description

Research Areas

This funding opportunity will support reviews and syntheses to address the most urgent elements of the opioid crisis, including reducing opioid-related mortality rates, relevant to one or more of the four pillars of the Canadian drugs and substances strategy (CDSS).

The CDSS is a comprehensive, collaborative, compassionate and evidence-based approach to drug policy. The four pillars of the strategy are:

  • – Prevention: Preventing problematic drug and substance use.
  • – Treatment: Supporting innovative approaches to treatment and rehabilitation.
  • – Harm reduction: Supporting measures that reduce the negative consequences of drug and substance use.
  • – Enforcement: Addressing illicit drug production, supply and distribution.

Additionally, applicants are encouraged to critically assess the state of knowledge on biological and social determinants of opioid use (e.g., sex, gender, age, housing status and income), and/or on sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, pregnant women and correctional populations) in relation to the CDSS.

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributionsto grants received as a result of this funding opportunity.

  • – The total amount available for this funding opportunity is $1,850,000.
  • – The maximum amount per grant is $110,000 for up to 6 months ($100,000 for knowledge synthesis, $10,000 to facilitate knowledge translation, such as for an end-of-grant knowledge exchange).
  • – The maximum amount for a scoping review is $60,000 for up to 6 months ($50,000 for the scoping review, $10,000 to facilitate knowledge translation, such as for an end-of-grant knowledge exchange).

Funding Sources

Canadian Institute of Health Research (CIHR)



This opportunity was posted by: RGCS

Last modified: September 21, 2017